Bone Marrow TransplantationCord Blood Stem Cell TransplantationTransplantation, HomologousFetal BloodHematopoietic Stem Cell TransplantationGraft vs Host DiseaseBone MarrowTransplantation ConditioningTransplantation ChimeraTissue DonorsHematologic NeoplasmsHistocompatibility TestingBone Marrow CellsTransplantation, AutologousStem CellsStem Cell TransplantationTreatment OutcomeHematopoietic Stem CellsWhole-Body IrradiationGraft SurvivalKidney TransplantationAnemia, AplasticLeukemiaBone and BonesHistocompatibilityBusulfanImmunosuppressive AgentsTransplantationGraft RejectionBone Marrow PurgingLiver TransplantationRecurrenceTime FactorsCytomegalovirus InfectionsCyclophosphamideRetrospective StudiesHematopoiesisCombined Modality TherapyHeart TransplantationTransplantation, IsogeneicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunocompromised HostPeripheral Blood Stem Cell TransplantationCell DifferentiationHepatic Veno-Occlusive DiseaseLeukemia, Myeloid, AcuteImmunosuppressionMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantsBone Marrow DiseasesLung TransplantationTransplantation ImmunologyOpportunistic InfectionsRemission InductionAcute DiseaseAntigens, CD34CyclosporineHematologic DiseasesSurvival AnalysisRadiation ChimeraHLA AntigensLymphocyte DepletionLeukocyte TransfusionEmbryonic Stem CellsLeukemia, MyeloidLymphoma, Non-HodgkinT-LymphocytesColony-Forming Units AssaySpinal CordSurvival RateCells, CulturedFollow-Up StudiesBone Marrow ExaminationHematopoietic Stem Cell MobilizationAdult Stem CellsFlow CytometryMyelodysplastic SyndromesMultiple MyelomaMesenchymal Stem Cell TransplantationFatal OutcomeAntineoplastic Combined Chemotherapy ProtocolsBone RemodelingGraft vs Host ReactionGraft vs Leukemia EffectAspergillosisBone Marrow NeoplasmsCytomegalovirusChimeraMycosesGranulocyte Colony-Stimulating FactorPostoperative ComplicationsOrgan TransplantationMelphalanSevere Combined ImmunodeficiencyDisease-Free SurvivalCell TransplantationCell LineageCell SeparationChimerism